Prevotella, commonly identified in the fecal samples of CHD patients (Chen et al., 2021), primarily activates toll-like receptor 2 and exhibits increased inflammatory properties that promote the recruitment of mucosal Th17 immune response and neutrophil (Larsen, 2017). Here, TLR2 is linked to coronary artery disorder.